NOVONIX Ltd Files Form 6-K for October 2025
Ticker: NVNXF · Form: 6-K · Filed: Oct 20, 2025 · CIK: 1859795
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
NOVONIX filed its monthly 6-K, standard procedure for foreign issuers, no major news.
AI Summary
NOVONIX Limited, a foreign private issuer, filed a Form 6-K on October 20, 2025, reporting for the month of October 2025. The company, incorporated in Australia with its principal executive office in Brisbane, is required to file annual reports under Form 20-F. This filing does not appear to contain specific financial figures or operational updates beyond its status as a periodic report.
Why It Matters
This filing indicates NOVONIX is meeting its reporting obligations as a foreign private issuer. Investors should review the full report for any material updates not summarized here.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- Form 6-K (document) — Filing type
- October 2025 (date) — Reporting period
- Form 20-F (document) — Annual report form
- Brisbane, QLD (location) — Principal executive office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company may be required to disclose or may make public in its home country.
What is NOVONIX Limited's filing status?
NOVONIX Limited is a foreign private issuer filing a Form 6-K for the month of October 2025.
What is NOVONIX's principal executive office location?
NOVONIX's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
Does NOVONIX file annual reports under Form 20-F or 40-F?
NOVONIX indicates it files annual reports under cover of Form 20-F.
What is the SEC file number for NOVONIX?
NOVONIX's SEC file number is 001-41208.
Filing Stats: 192 words · 1 min read · ~1 pages · Grade level 13.7 · Accepted 2025-10-20 07:08:42
Filing Documents
- nvx-6k-oct-25--17_form_6.htm (6-K) — 28KB
- nvx-ex99_1.htm (EX-99.1) — 83KB
- 0001193125-25-242994.txt ( ) — 112KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Robert Long Robert Long Chief Financial Officer Date: October 20, 2025